Fiterman Center Exclusion: Insertion: NS dislodgement in the for Digestive pyriform sinus Level: IV Not stated Placement: 6 cm above the SCJ Diseases, Mayo Quality: Q2 Duration: 48 hours Clinic, Rochester, Minnesota, USA CX (no Comparator: NA comparator) P2 Chest pain (adj OR) Francis, DO et al. Randomised, 22 patients were included (13 males, Inclusion: Index test: Odynophagia (adj () blinded controlled 9 females) Patients >18 years of age, scheduled for System: Bravo™ wireless capsule system OR) trial Division of Indications: planned oesophagogastroduodenoscopy Insertion: transorally Dysphagia (adj OR) Gastroenterology, and wireless pH monitoring for Cough, hoarseness, globus, Placement: 16 cm above the SCJ Hepatology and physiologic assessment of oesophageal Level: II heartburn, regurgitation Nutrition, acid exposure for typical GORD Duration: 48 hours Quality: 16/26 Vanderbilt symptoms or for extraoesophageal reflux Comparator: University (EER) symptoms C1 Medical Center, No monitoring (a sham capsule placement) Exclusion: P2 Nashville, History of upper oesophageal surgery, Tennessee, USA bleeding dyscrasia, recent cerebrovascular accident or transient ischemic attack, recent (<6 months) GI haemorrhage, oesophageal varices or significant medical illness, current pregnancy Back pain Garrean et al. () Case series 60 patients (22 males and 38 Inclusion: Index test: Globus sensation (prospective?) females) Division of Not stated System: Bravo™ wireless capsule system Chest pain Gastroenterology, Age: 19–80 years Exclusion: Insertion: NS Northwestern Level: IV 40 patients had complete 4-day data Not stated Placement: 6 cm above the SCJ University acquisition Quality: Q2 Freiberg School Comparator: NA Indications: of Medicine, CX (no Chicago, Illinois, comparator) acid reflux symptoms, chest pain, USA laryngeal symptoms that were poorly
Fiterman Center for Digestive Diseases, Mayo Clinic, Rochester, Minnesota, USA Level: IV Quality: Q2 CX (no comparator) P2 Exclusion: Not stated Insertion: NS Placement: 6 cm above the SCJ Duration: 48 hours Comparator: NA dislodgement in the pyriform sinus Francis, DO et al. () Division of Gastroenterology, Hepatology and Nutrition, Vanderbilt University Medical Center, Nashville, Tennessee, USA Randomised, blinded controlled trial Level: II Quality: 16/26 C1 P2 22 patients were included (13 males, 9 females) Indications: Cough, hoarseness, globus, heartburn, regurgitation Inclusion: Patients >18 years of age, scheduled for planned oesophagogastroduodenoscopy and wireless pH monitoring for physiologic assessment of oesophageal acid exposure for typical GORD symptoms or for extraoesophageal reflux (EER) symptoms Exclusion: History of upper oesophageal surgery, bleeding dyscrasia, recent cerebrovascular accident or transient ischemic attack, recent (<6 months) GI haemorrhage, oesophageal varices or significant medical illness, current pregnancy Index test: System: Bravo™ wireless capsule system Insertion: transorally Placement: 16 cm above the SCJ Duration: 48 hours Comparator: No monitoring (a sham capsule placement) Chest pain (adj OR) Odynophagia (adj OR) Dysphagia (adj OR) Garrean et al. () Division of Gastroenterology, Northwestern University Freiberg School of Medicine, Chicago, Illinois, USA Case series (prospective?) Level: IV Quality: Q2 CX (no comparator) 60 patients (22 males and 38 females) Age: 19–80 years 40 patients had complete 4-day data acquisition Indications: acid reflux symptoms, chest pain, laryngeal symptoms that were poorly Inclusion: Not stated Exclusion: Not stated Index test: System: Bravo™ wireless capsule system Insertion: NS Placement: 6 cm above the SCJ Comparator: NA Back pain Globus sensation Chest pain
1203-ContractedAssessmentReport-Catheter-free%20ambulatory%20pH%20test%20for%20GORD%20accessible.docx